Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 3 crawled date : 2021 - 09 - 27 save search
Altimmune to Announce 12-Week Data From ALT-801 Phase 1 Trial on September 28, 2021
Published: 2021-09-27 (Crawled : 23:00) - globenewswire.com
ALT | $6.91 0.29% 0.29% 3.6M
|
Commercial Services
|
| O: -28.7%
H: 39.15%
C: 36.75%
phase 1 trial phase 2 phase 3
New Phase 3 Data Suggest Positive Effect and Show Similar Safety with XARELTO® (rivaroxaban) Compared to Aspirin in Pediatric Fontan Procedure Patients at Risk for Blood Clots and Blood Clot-Related Events
Published: 2021-09-27 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.44%
H: 0.22%
C: -0.51%
blood risk positive phase 3
Phathom Pharmaceuticals Announces Results from VONO-103, a Phase 1 Study Evaluating Gastric Acid Inhibition of Vonoprazan and Lansoprazole (PREVACID®)
Published: 2021-09-27 (Crawled : 13:00) - biospace.com/
PHAT | $8.98 -5.27% -5.57% 590K
|
Health Technology
|
| O: 1.13%
H: 4.5%
C: 2.11%
phase 1 results phase 2 phase 3
Biohaven Provides Update On Phase 3 Trial And Multiple System Atrophy (MSA) Program
Published: 2021-09-27 (Crawled : 12:00) - biospace.com/
BHVN 1 d | $38.99 -7.52% 0.0% 3.4M
|
Health Technology
|
| O: -3.57%
H: 2.18%
C: 0.94%
phase 3 trial
Intra-Cellular Therapies Announces Publication of Lumateperone Pivotal Phase 3 Study in Bipolar Depression in The American Journal of Psychiatry
Published: 2021-09-27 (Crawled : 12:00) - globenewswire.com
ITCI 1 d | $72.29 0.4% 0.4% 2.2M
|
Health Technology
|
| O: -1.58%
H: 3.97%
C: 2.66%
depression phase 3 therapy
ADC Therapeutics Doses First Patient in Phase 1 Clinical Trial of ADCT-901 in Advanced Solid Tumors
Published: 2021-09-27 (Crawled : 12:00) - biospace.com/
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: -1.15%
H: 5.45%
C: 4.36%
solid tumors phase 1 trial phase 2 phase 3
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.